ADXS - AdvaxisAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $0.56 | Open | $0.56 |
| Volume | 539.6K | Market Cap | 34.44M |
| Yield | Last Dividend |
| Advaxis Reports Fiscal Year 2019 Financi... | 12/20/19 |
| PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company focused on the development and commercialization... | |
| Advaxis to Present at 12th Annual LD Mic... | 12/04/19 |
| PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercializatio... | |
| Advaxis Announces Submission of IND Appl... | 12/03/19 |
| PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercializatio... | |
| The Daily Biotech Pulse: Enanta Aces Mid... | 09/26/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs S... | |
| The Daily Biotech Pulse: PhaseBio Leaps ... | 09/25/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 24)... | |
| The Daily Biotech Pulse: Translate Bio H... | 09/10/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| The Daily Biotech Pulse: EC Nod For Bris... | 08/28/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 27) ... | |
| The Daily Biotech Pulse: Nuvectra Explor... | 08/27/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 26) ... | |
| The Daily Biotech Pulse: Jazz Goes Shopp... | 08/13/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 12) ... | |
| The Daily Biotech Pulse: European Cheer ... | 07/30/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 29) ... | |
| The Daily Biotech Pulse: Jounce Jumps On... | 07/24/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 23) ... | |
| The Daily Biotech Pulse: Roche Presents ... | 07/09/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 8) A... | |
| The Daily Biotech Pulse: Merrimack To St... | 05/31/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 30) A... | |
| FDA lifts partial hold on late-stage stu... | 05/15/19 |
| No summary available. | |
| Advaxis (ADXS) Stock Sinks As Market Gai... | 04/18/19 |
| Advaxis (ADXS) closed the most recent trading day at $3.29, moving -0.3% from the previous trading session. | |
| Zynerba Pharmaceuticals and Sorrento The... | 04/03/19 |
| No summary available. | |
| The Daily Biotech Pulse: Advaxis Offerin... | 04/03/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 2) ... | |
| Advaxis down 26% on pricing stock offeri... | 04/03/19 |
| No summary available. | |
| PLAY, GME and ADXS among after hours mov... | 04/02/19 |
| No summary available. | |
| WBA, EVOK and UGI among premarket losers | 04/02/19 |
| No summary available. | |
| Why Wynn Resorts, Advaxis, and Roku Jump... | 04/01/19 |
| These stocks jumped on a strong start to the second quarter. | |
| Why Advaxis Stock Skyrocketed 13.8% Toda... | 04/01/19 |
| The small-cap biotech reported encouraging news about its prostate cancer therapy. | |
| CEL-SCI and Advaxis among healthcare gai... | 04/01/19 |
| No summary available. | |
| Advaxis up 39% premarket on positive ADX... | 04/01/19 |
| Thinly traded micro cap Advaxis (ADXS) is up 39% premarket on robust volume in response to updated data from an open-label Phase 1/2 clinical trial, K... | |
| Advaxis up 5% premarket on positive ADXS... | 04/01/19 |
| No summary available. | |
| Will Advaxis Continue to Surge Higher? | 03/29/19 |
| As of late, it has definitely been a great time to be an investor in Advaxis. | |
| Advaxis -11.2% on announcing reverse sto... | 03/28/19 |
| No summary available. | |
| Has Advaxis (ADXS) Outpaced Other Medica... | 03/22/19 |
| Is (ADXS) Outperforming Other Medical Stocks This Year? | |
| Advaxis reports Q1 results | 03/12/19 |
| No summary available. | |
| Enrollment underway in study of Advaxis ... | 02/14/19 |
| No summary available. | |
| Date | 2020-06-11 (BMO) | Est. (EPS/Rev.) | ($0.15)/ 0 |
| Actual (EPS/Rev.) | $-0.10/ $250.00 K | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Arbitrage Trade Analytics | Royce Wells | 71.00 % | Subscribe |
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 65.00 % | Follow |
| Biotechnology | Robert Gadimian | 26.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
